3,116 results on '"Curcumin therapeutic use"'
Search Results
2. Efficacy assessment of miltefosine and curcumin against Clonorchis sinensis infection.
- Author
-
Lee S-O, Chu KB, Yoon K-W, Eom G-D, Mao J, Lee H, No JH, Song JH, Hong S-J, Kim SS, and Quan F-S
- Subjects
- Animals, Mesocricetus, Larva drug effects, Cricetinae, Male, Metacercariae drug effects, Clonorchis sinensis drug effects, Curcumin pharmacology, Curcumin therapeutic use, Clonorchiasis drug therapy, Clonorchiasis parasitology, Phosphorylcholine analogs & derivatives, Phosphorylcholine therapeutic use, Phosphorylcholine pharmacology, Anthelmintics therapeutic use, Anthelmintics pharmacology, Praziquantel pharmacology, Praziquantel therapeutic use
- Abstract
Praziquantel (PZQ) is currently the only approved drug for treating clonorchiasis, but its poor efficacy against Clonorchis sinensis larvae has highlighted the need to develop newer drugs. In this study, to address this challenge, we investigated the anti-parasitic efficacy of miltefosine (MLT), curcumin (CUR), and PZQ against C. sinensis metacercariae (CsMC), newly excysted juvenile worms (CsNEJs), and adults. Larvicidal effects of MLT and CUR surpassed those elicited by PZQ in vitro . These two drugs exerted their effect against both CsMC and CsNEJs in a dose- and time-dependent manner. To confirm the effect of these drugs in vivo , Syrian golden hamsters were orally infected with 100 CsMC and subsequently treated with MLT, CUR, or PZQ at 1 and 4 weeks post-infection (wpi). MLT and CUR reduced the worm recoveries at 1 and 4 wpi, indicating that these drugs were efficacious against both larvae and adult C. sinensis . PZQ was only efficacious against adult worms. Interestingly, both MLT and CUR showed lower levels of C. sinensis- specific IgG responses than the infection control group, implying that worm burden and bile IgG responses could be correlated. These results indicate that MLT and CUR are efficacious against both larval and adult stages of C. sinensis , thereby highlighting their potential for further development as alternative therapeutic options for clonorchiasis., Competing Interests: The authors declare no conflict of interest.
- Published
- 2024
- Full Text
- View/download PDF
3. Targeting the Akt signaling pathway: Exploiting curcumin's anticancer potential.
- Author
-
Aliyari M, Hashemy SI, Hashemi SF, Reihani A, Kesharwani P, Hosseini H, and Sahebkar A
- Subjects
- Humans, Antineoplastic Agents therapeutic use, Antineoplastic Agents pharmacology, Animals, Curcumin therapeutic use, Curcumin pharmacology, Signal Transduction drug effects, Proto-Oncogene Proteins c-akt metabolism, Neoplasms drug therapy, Neoplasms pathology, Neoplasms metabolism
- Abstract
Cancer is recognized as one of the leading causes of death worldwide. In recent years, advancements in early detection and expanding treatment options have contributed to a decrease in mortality rates. However, the emergence of drug-resistant cancers necessitates the exploration of innovative and more effective drugs. The Akt kinases play a central role in various signaling pathways that regulate crucial cellular processes, including cell growth, proliferation, survival, angiogenesis, and glucose metabolism. Due to frequent disruptions of the Akt signaling pathway in numerous human cancers and its broad biological implications, targeting this pathway has become a key focus in combating tumor aggressiveness and a promising avenue for therapeutic intervention. Curcumin, a compound found in turmeric, has been extensively studied for its potential as an anti-cancer agent. It demonstrates inhibitory effects on cancer initiation, progression, and metastasis by influencing various processes involved in tumor growth and development. These effects are achieved through negative regulation of transcription factors, growth factors, cytokines, protein kinases, and other oncogenic molecules. This review aims to explore curcumin's anticancer activity against different types of cancer mediated via the PI3K/Akt signaling pathway, as well as its practical applications in treatment., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier GmbH. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
4. Tetrahydrocurcumin Protects Against GSK3β/PTEN/PI3K/Akt-Mediated Neuroinflammatory Responses and Microglial Polarization Following Traumatic Brain Injury.
- Author
-
Zhang J, Gu Y, Sun W, Yu L, and Li T
- Subjects
- Animals, Male, Rats, Apoptosis drug effects, Neuroprotective Agents pharmacology, Neuroprotective Agents therapeutic use, Brain Injuries, Traumatic pathology, Brain Injuries, Traumatic metabolism, Brain Injuries, Traumatic drug therapy, Cell Polarity drug effects, Curcumin pharmacology, Curcumin analogs & derivatives, Curcumin therapeutic use, Glycogen Synthase Kinase 3 beta metabolism, Microglia drug effects, Microglia metabolism, Microglia pathology, Neuroinflammatory Diseases drug therapy, Neuroinflammatory Diseases metabolism, Neuroinflammatory Diseases pathology, Phosphatidylinositol 3-Kinases metabolism, Proto-Oncogene Proteins c-akt metabolism, PTEN Phosphohydrolase metabolism, Rats, Sprague-Dawley, Signal Transduction drug effects
- Abstract
Tetrahydrocurcumin (THC) and microglial polarization play crucial roles in neuroprotection during traumatic brain injury (TBI). However, whether THC regulates microglial polarization in TBI is unknown. Thus, we intended to analyze the functions and mechanism of THC in nerve injury after TBI via the regulation of microglial polarization. A TBI rat model was established, and modified neurological function score (mNSS), brain water content, Nissl staining, and Fluoro-Jade B (FJB) staining were used to evaluate neurological function. The expression of the M1-linked markers CD16 and CD86, as well as the M2-associated markers CD206 and YM-1, was analyzed via qRT-PCR, western blotting, and immunofluorescence. The levels of inflammatory cytokines were assessed via ELISA. Primary microglia were isolated from the brain and treated with lipopolysaccharide (LPS) to induce injury. TUNEL staining was used to measure primary microglial apoptosis. The expression of GSK3β, PTEN, and PI3K/Akt pathway proteins was detected via western blotting. TBI induced nerve injury, while THC improved neurological function recovery after TBI. Further analysis indicated that THC enhanced M2 microglial polarization and attenuated the inflammatory reaction mediated by microglia both in vitro and in vivo. Moreover, we found that THC promoted the M2 microglial phenotype through upregulating GSK3β expression. Additionally, we proved that GSK3β activated the PI3K/Akt pathway by phosphorylating PTEN. In conclusion, we demonstrated that THC protected against nerve injury after TBI via microglial polarization via the GSK3B/PTEN/PI3K/Akt signaling axis, suggesting the potential of THC for TBI treatment by promoting microglial M2 polarization., (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
5. Epigenetic Orchestration of Neurodegenerative Disorders: A Possible Target for Curcumin as a Therapeutic.
- Author
-
Tripathi S and Bhawana
- Subjects
- Humans, Animals, Mitochondria metabolism, Mitochondria drug effects, Oxidative Stress drug effects, Curcumin therapeutic use, Curcumin pharmacology, Epigenesis, Genetic drug effects, Neurodegenerative Diseases drug therapy, Neurodegenerative Diseases metabolism, Neurodegenerative Diseases genetics, Neuroprotective Agents therapeutic use, Neuroprotective Agents pharmacology
- Abstract
Epigenetic modulations play a major role in gene expression and thus are responsible for various physiological changes including age-associated neurological disorders. Neurodegenerative diseases such as Alzheimer's (AD), Parkinson's (PD), Huntington's disease (HD), although symptomatically different, may share common underlying mechanisms. Most neurodegenerative diseases are associated with increased oxidative stress, aggregation of certain proteins, mitochondrial dysfunction, inactivation/dysregulation of protein degradation machinery, DNA damage and cell excitotoxicity. Epigenetic modulations has been reported to play a significant role in onset and progression of neurodegenerative diseases by regulating these processes. Previous studies have highlighted the marked antioxidant and neuroprotective abilities of polyphenols such as curcumin, by increased activity of detoxification systems like superoxide dismutase (SOD), catalase or glutathione peroxidase. The role of curcumin as an epigenetic modulator in neurological disorders and neuroinflammation apart from other chronic diseases have also been reported by a few groups. Nonetheless, the evidences for the role of curcumin mediated epigenetic modulation in its neuroprotective ability are still limited. This review summarizes the current knowledge of the role of mitochondrial dysfunction, epigenetic modulations and mitoepigenetics in age-associated neurological disorders such as PD, AD, HD, Amyotrophic Lateral Sclerosis (ALS), and Multiple Sclerosis (MS), and describes the neuroprotective effects of curcumin in the treatment and/or prevention of these neurodegenerative diseases by regulation of the epigenetic machinery., (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
6. Curcumin as a potential therapeutic agent for treating neurodegenerative diseases.
- Author
-
Perales-Salinas V, Purushotham SS, and Buskila Y
- Subjects
- Humans, Animals, Neuroprotective Agents therapeutic use, Neuroprotective Agents pharmacology, Antioxidants therapeutic use, Antioxidants pharmacology, Curcumin therapeutic use, Curcumin pharmacology, Neurodegenerative Diseases drug therapy, Neurodegenerative Diseases metabolism
- Abstract
Neurodegenerative diseases are characterized by the progressive loss of neuronal structure and function, posing a tremendous burden on health systems worldwide. Although the underlying pathological mechanisms for various neurodegenerative diseases are still unclear, a common pathological hallmark is the abundance of neuroinflammatory processes, which affect both disease onset and progression. In this review, we explore the pathways and role of neuroinflammation in various neurodegenerative diseases and further assess the potential use of curcumin, a natural spice with antioxidant and anti-inflammatory properties that has been extensively used worldwide as a traditional medicine and potential therapeutic agent. Following the examination of preclinical and clinical studies that assessed curcumin as a potential therapeutic agent, we highlight the bioavailability of curcumin in the body and discuss both the challenges and benefits of using curcumin as a therapeutic compound for treating neurodegeneration. Although elucidating the involvement of curcumin in aging and neurodegeneration has great potential for developing future CNS-related therapeutic targets, further research is required to elucidate the mechanisms by which Curcumin affects brain physiology, especially BBB integrity, under both physiological and disease conditions., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Valeria Perales-Salinas reports financial support was provided by Indena SpA. Sushmitha S. Purushotham reports financial support was provided by Indena SpA. Yossi Buskila reports a relationship with Indena SpA that includes: funding grants. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
7. Anti-PD-L1 antibody retains antitumour effects while mitigating immunotherapy-related colitis in bladder cancer-bearing mice after CT-mediated intratumoral delivery.
- Author
-
Wang YS, Zheng AH, Zhao JW, Gu HY, Meng ZN, Chen JY, Wang FW, Zhu XM, Chen Y, Xu SC, Sun LT, Lai WF, Wu GQ, and Zhang DH
- Subjects
- Animals, Mice, Humans, Cell Line, Tumor, Female, Colitis chemically induced, Colitis immunology, Colitis drug therapy, Tumor Microenvironment drug effects, Tumor Microenvironment immunology, Drug Delivery Systems, Disease Models, Animal, Mice, Inbred C57BL, Antineoplastic Agents, Immunological administration & dosage, Antineoplastic Agents, Immunological therapeutic use, Colitis, Ulcerative chemically induced, Colitis, Ulcerative drug therapy, Colitis, Ulcerative immunology, Urinary Bladder Neoplasms drug therapy, Urinary Bladder Neoplasms immunology, Urinary Bladder Neoplasms therapy, B7-H1 Antigen antagonists & inhibitors, B7-H1 Antigen immunology, Curcumin therapeutic use, Curcumin administration & dosage, Immunotherapy methods, Immune Checkpoint Inhibitors therapeutic use
- Abstract
Drug local delivery system that directly supply anti-cancer drugs to the tumor microenvironment (TME) results in excellent tumor control and minimizes side effects associated with the anti-cancer drugs. Immune checkpoint inhibitors (ICIs) have been the mainstay of cancer immunotherapy. However, the systemic administration of ICIs is accompanied by considerable immunotherapy-related toxicity. To explore whether an anti-PD-L1 antibody administered locally via a sustained-release gel-forming carrier retains its effective anticancer function while causing fewer colitis-like side effects, CT, a previously reported depot system, was used to locally deliver an anti-PD-L1 antibody together with curcumin to the TME in bladder cancer-bearing ulcerative colitis model mice. We showed that CT-mediated intratumoral coinjection of an anti-PD-L1 antibody and curcumin enabled sustained release of both the loaded anti-PD-L1 antibody and curcumin, which contributed to substantial anticancer effects with negligible side effects on the colons of the UC model mice. However, although the anti-PD-L1 antibody administered systemically synergized with the CT-mediated intratumoral delivery of curcumin in inhibiting tumour growth, colitis was significantly worsened by intraperitoneal administration of anti-PD-L1 antibody. These findings suggested that CT is a promising agent for the local delivery of anticancer drugs, as it can allow effective anticancer functions to be retained while sharply reducing the adverse side effects associated with the systemic administration of these drugs., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
8. Polyphenols in the Prevention and Treatment of Colorectal Cancer: A Systematic Review of Clinical Evidence.
- Author
-
López-Gómez L and Uranga JA
- Subjects
- Humans, Curcumin pharmacology, Curcumin therapeutic use, Adenoma prevention & control, Adenoma drug therapy, Colorectal Neoplasms prevention & control, Colorectal Neoplasms drug therapy, Polyphenols pharmacology
- Abstract
Polyphenols are plant metabolites with potential anti-inflammatory and anti-proliferative effects, which may be advantageous for disorders like colorectal cancer (CRC). Despite promising in vitro and in vivo evidence, human clinical trials have yielded mixed results. The present study aimed to evaluate the clinical evidence of polyphenols for CRC prevention or treatment. A systematic review was performed according to PRISMA. Based on a PROSPERO registered protocol (CRD42024560044), online databases (PubMed and COCHRANE) were utilized for the literature search. A total of 100 studies articles were initially identified. After reviewing, 12 studies with a low risk of bias were selected, examining the effect of a variety of compounds. Curcumin demonstrated promise in various trials, mainly decreasing inflammatory cytokines, though results varied, and it did not lower intestinal adenomas or improve outcomes after chemotherapy. Neither epigallocatechin gallate nor artepillin C reduced the incidence of adenomas. Finally, fisetin seemed to improve the inflammatory status of patients under chemotherapy (5-fluorouracil). In summary, although certain polyphenols appear to exert some effect, their role in the prevention or treatment of CRC is inconclusive, and more clinical studies under more controlled conditions are needed.
- Published
- 2024
- Full Text
- View/download PDF
9. Curcumin: A Golden Approach to Healthy Aging: A Systematic Review of the Evidence.
- Author
-
Nunes YC, Mendes NM, Pereira de Lima E, Chehadi AC, Lamas CB, Haber JFS, Dos Santos Bueno M, Araújo AC, Catharin VCS, Detregiachi CRP, Laurindo LF, Tanaka M, Barbalho SM, and Marin MJS
- Subjects
- Humans, Oxidative Stress drug effects, Dietary Supplements, Aged, Quality of Life, Aging drug effects, Cognition drug effects, Anti-Inflammatory Agents pharmacology, Curcumin pharmacology, Curcumin therapeutic use, Healthy Aging, Antioxidants pharmacology
- Abstract
Aging-related disorders pose significant challenges due to their complex interplay of physiological and metabolic factors, including inflammation, oxidative stress, and mitochondrial dysfunction. Curcumin, a natural compound with potent antioxidant and anti-inflammatory properties, has emerged as a promising candidate for mitigating these age-related processes. However, gaps in understanding the precise mechanisms of curcumin's effects and the optimal dosages for different conditions necessitate further investigation. This systematic review synthesizes current evidence on curcumin's potential in addressing age-related disorders, emphasizing its impact on cognitive function, neurodegeneration, and muscle health in older adults. By evaluating the safety, efficacy, and mechanisms of action of curcumin supplementation, this review aims to provide insights into its therapeutic potential for promoting healthy aging. A systematic search across three databases using specific keywords yielded 2256 documents, leading to the selection of 15 clinical trials for synthesis. Here, we highlight the promising potential of curcumin as a multifaceted therapeutic agent in combating age-related disorders. The findings of this review suggest that curcumin could offer a natural and effective approach to enhancing the quality of life of aging individuals. Further research and well-designed clinical trials are essential to validate these findings and optimize the use of curcumin in personalized medicine approaches for age-related conditions.
- Published
- 2024
- Full Text
- View/download PDF
10. The synergistic effect of curcumin and mitoquinol mesylate on cognitive impairment and the neuropathology of Alzheimer's disease.
- Author
-
Xie Y, Li X, Shi Q, Le L, Wang C, Xu H, Wu G, Du X, and Chen Z
- Subjects
- Animals, Mice, Brain drug effects, Brain pathology, Brain metabolism, Phosphorylation drug effects, Humans, Curcumin pharmacology, Curcumin therapeutic use, Alzheimer Disease drug therapy, Alzheimer Disease pathology, Mice, Transgenic, Cognitive Dysfunction drug therapy, Disease Models, Animal, Drug Synergism, tau Proteins metabolism, Amyloid beta-Peptides metabolism
- Abstract
Given the complexity and heterogeneity of Alzheimer's disease (AD) pathology, targeted monotherapy drugs may not be effective. Therefore, synergistic combination therapy of curcumin and Mito Q was proposed and evaluated in a triple-transgenic AD model mice (3 × Tg-AD mice). The cognitive ability was assessed using behavioral tests and typical pathological changes were observed through Western blotting and histological analysis. The results demonstrated a significant enhancement in cognitive ability along with the mitigation of typical AD pathological features such as Aβ aggregation, tau phosphorylation, and synaptic damage. Notably, the combination therapy demonstrated superior efficacy over individual drugs alone. These findings provide valuable insights for optimizing the development of AD drugs., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
11. Oral enzyme-responsive nanoprobes for targeted theranostics of inflammatory bowel disease.
- Author
-
Cao L, Duan D, Peng J, Li R, Cao Q, Li X, Guo Y, Li J, Liu K, Li Y, Zhang W, Liu S, Zhang X, and Zhao Y
- Subjects
- Animals, Mice, Administration, Oral, Hyaluronoglucosaminidase metabolism, Tomography, X-Ray Computed, Mice, Inbred C57BL, Colon diagnostic imaging, Colon pathology, Colon metabolism, Humans, Colitis drug therapy, Inflammatory Bowel Diseases drug therapy, Cerium chemistry, Curcumin pharmacology, Curcumin chemistry, Curcumin therapeutic use, Theranostic Nanomedicine methods, Nanoparticles chemistry, Hyaluronic Acid chemistry
- Abstract
Background: Inflammatory bowel disease (IBD) is a progressive and debilitating inflammatory disease of the gastrointestinal tract (GIT). Despite recent advances, precise treatment and noninvasive monitoring remain challenging., Methods: Herein, we developed orally-administered, colitis-targeting and hyaluronic acid (HA)-modified, core-shell curcumin (Cur)- and cerium oxide (CeO
2 )-loaded nanoprobes (Cur@PC-HA/CeO2 NPs) for computed tomography (CT) imaging-guided treatment and monitoring of IBD in living mice., Results: Following oral administration, high-molecular-weight HA maintains integrity with little absorption in the upper GIT, and then actively accumulates at local colitis sites owing to its colitis-targeting ability, leading to specific CT enhancement lasting for 24 h. The retained NPs are further degraded by hyaluronidase in the colon to release Cur and CeO2 , thereby exerting anti-inflammatory and antioxidant effects. Combined with the ability of NPs to regulate intestinal flora, the oral NPs result in substantial relief in symptoms. Following multiple treatments, the gradually decreasing range of the colon with high CT attenuation correlates with the change in the clinical biomarkers, indicating the feasibility of treatment response and remission., Conclusion: This study provides a proof-of-concept for the design of a novel theranostic integration strategy for concomitant IBD treatment and the real-time monitoring of treatment responses., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
12. Evaluation of the protective effect of Curcuma longa and PPARγ agonist, pioglitazone on paraquat-induced lung injury in rats.
- Author
-
Eshaghi Ghalibaf MH, Taghavi Zadeh Yazdi ME, Mansourian M, Mohammadian Roshan N, and Boskabady MH
- Subjects
- Animals, Male, Rats, Lung pathology, Lung drug effects, Lung metabolism, Lung Injury chemically induced, Lung Injury prevention & control, Lung Injury drug therapy, Lung Injury pathology, Lung Injury metabolism, Dexamethasone pharmacology, Bronchoalveolar Lavage Fluid cytology, Oxidative Stress drug effects, Thiazolidinediones pharmacology, Thiazolidinediones therapeutic use, Antioxidants pharmacology, Curcumin pharmacology, Curcumin therapeutic use, Pioglitazone pharmacology, Pioglitazone therapeutic use, Paraquat toxicity, Rats, Wistar, Curcuma chemistry, PPAR gamma agonists, PPAR gamma metabolism, Plant Extracts pharmacology, Plant Extracts therapeutic use
- Abstract
Background: The inhalation of paraquat (PQ), one of the most widely used herbicides in the world, can result in lung injury. Curcuma longa (Cl) has long history in traditional and folk medicine for the treatment of a wide range of disorders including respiratory diseases., Aim: The aim of the present work was to evaluate the preventive effect of Cl on inhaled PQ-induced lung injury in rats., Methods: Male Wistar rats were divided into 8 groups (n = 7), one group exposed to saline (control) and other groups exposed to PQ aerosol. Saline (PQ), Cl extract, (two doses), curcumin (Cu), pioglitazone (Pio), and the combination of Cl-L + Pio and dexamethasone (Dex) were administered during the exposure period to PQ. Total and differential white blood cell (WBC) counts, oxidant and antioxidant indicators in the bronchoalveolar lavage (BALF), interleukin (IL)-10, and tumor necrosis alpha (TNF-α) levels in the lung tissues, lung histologic lesions score, and air way responsiveness to methacholine were evaluated., Results: WBC counts (Total and differential), malondialdehyde level, tracheal responsiveness (TR), IL-10, TNF-α and histopathological changes of the lung were markedly elevated but total thiol content and the activities of catalase and superoxide dismutase were decreased in the BALF in the PQ group. Both doses of Cl, Cu, Pio, Cl-L + Pio, and Dex markedly improved all measured variables in comparison with the PQ group., Conclusion: CI, Pio, and Cl-L + Pio improved PQ-induced lung inflammation and oxidative damage comparable with the effects of Dex., (© 2024 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
13. The Efficacy of Curcumin Application to Melanoma in Mice: A Systematic Review and Meta-analysis.
- Author
-
Teng L, Li W, Shi Y, and Qi F
- Subjects
- Animals, Mice, Disease Models, Animal, Antineoplastic Agents therapeutic use, Antineoplastic Agents pharmacology, Treatment Outcome, Curcumin pharmacology, Curcumin therapeutic use, Skin Neoplasms drug therapy, Skin Neoplasms pathology, Melanoma drug therapy, Melanoma pathology
- Abstract
Objective: Melanoma is a skin tumor that poses a serious threat to human health. Our study explores the effectiveness and safety of curcumin in the treatment of melanoma based on animal models, and providing evidence-based medical evidence for curcumin in the treatment of malignant melanoma., Methods: The study collected all randomized controlled trial data from the establishment of the database to October 2023 of curcumin for the treatment of melanoma in mice by searching PubMed, Embase, and the Cochrane Library. According to inclusion and exclusion criteria, data were extracted and quality assessment of included studies was performed by using the SYRCLE (Systematic Review Center for Laboratory animal Experimentation) animal experiment bias risk assessment tool. RevMan 5.4 and Stata 15.1 software were used for meta-analysis., Results: Eighteen randomized controlled trials were included in this study with a total of 185 mouse models, including 93 mice in the experimental group and 92 in the control group. The results of meta-analysis showed that the IC50 (inhibitory concentrations of 50%) in the experimental group is lower than that of the control group [standardized mean difference (SMD) = -4.68, 95% confidence interval (CI) (-7.30, -2.06), P < 0.01]; the tumor volume is significantly smaller than the control group [SMD = -3.10, 95% CI (-4.45, -1.75), P < 0.01]; the tumor weight is smaller than the control group [SMD = -3.01, 95% CI (-4.81, -1.21), P < 0.01]. However, there was no significant statistical difference in the apoptosis rate between the experimental group and the control group [SMD = 2.27, 95% CI (-1.39, 5.92), P < 0.01]., Conclusion: Based on animal models for meta-analysis, curcumin can inhibit the growth and proliferation of melanoma in mice. Melanoma may be an effective method for treating melanoma. However, this result still requires further in-depth research., Competing Interests: Conflicts of interest and sources of funding: none declared., (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
14. Curcumin and nano-curcumin applications in psychiatric disorders.
- Author
-
Mohammadzadeh R, Fathi M, Pourseif MM, Omidi Y, Farhang S, Barzegar Jalali M, Valizadeh H, Nakhlband A, and Adibkia K
- Subjects
- Humans, Antidepressive Agents pharmacology, Antidepressive Agents therapeutic use, Schizophrenia drug therapy, Anxiety Disorders drug therapy, Animals, Liposomes chemistry, Curcumin pharmacology, Curcumin therapeutic use, Curcumin chemistry, Bipolar Disorder drug therapy, Nanoparticles chemistry, Depressive Disorder, Major drug therapy, Mental Disorders drug therapy
- Abstract
Psychiatric disorders cause long-lasting disabilities across different age groups. While various medications are available for mental disorders, some patients do not fully benefit from them or experience treatment resistance. The pathogenesis of psychiatric disorders involves multiple mechanisms, including an increase in the inflammatory response. Targeting inflammatory mechanisms has shown promise as a therapeutic approach for these disorders. Curcumin, known for its anti-inflammatory properties and potential neuroprotective effects, has been the subject of studies investigating its potential as a treatment option for psychiatric disorders. This review comprehensively examines the potential therapeutic role of curcumin and its nanoformulations in psychiatric conditions, including major depressive disorder (MDD), bipolar disorder, schizophrenia, and anxiety disorders. There is lack of robust clinical trials across all the studied psychiatric disorders, particularly bipolar disorder and schizophrenia. More studies have focused on MDD. Studies on depression indicate that curcumin may be effective as an antidepressant agent, either alone or as an adjunct therapy. However, inconsistencies exist among study findings, highlighting the need for further research with improved blinding, optimized dosages, and treatment durations. Limited evidence supports the use of curcumin for bipolar disorder, making its therapeutic application challenging. Well-designed clinical trials are warranted to explore its potential therapeutic benefits. Exploring various formulations and delivery strategies, such as utilizing liposomes and nanoparticles, presents intriguing avenues for future research. More extensive clinical trials are needed to assess the efficacy of curcumin as a standalone or adjunctive treatment for psychiatric disorders, focusing on optimal dosages, formulations, and treatment durations., (© 2024 John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
15. Curcumin-loaded polymeric nanomaterials as a novel therapeutic strategy for Alzheimer's disease: A comprehensive review.
- Author
-
Pei J, Palanisamy CP, Natarajan PM, Umapathy VR, Roy JR, Srinivasan GP, Panagal M, and Jayaraman S
- Subjects
- Humans, Animals, Polymers, Nanoparticles administration & dosage, Drug Delivery Systems methods, Neuroprotective Agents administration & dosage, Neuroprotective Agents therapeutic use, Neuroprotective Agents pharmacology, Curcumin administration & dosage, Curcumin therapeutic use, Alzheimer Disease drug therapy, Nanostructures
- Abstract
Alzheimer's disease (AD) stands as a formidable challenge in modern medicine, characterized by progressive neurodegeneration, cognitive decline, and memory impairment. Despite extensive research, effective therapeutic strategies remain elusive. The antioxidant, anti-inflammatory, and neuroprotective properties of curcumin, found in turmeric, have demonstrated promise. The poor bioavailability and rapid systemic clearance of this drug limit its clinical application. This comprehensive review explores the potential of curcumin-loaded polymeric nanomaterials as an innovative therapeutic avenue for AD. It delves into the preparation and characteristics of diverse polymeric nanomaterial platforms, including liposomes, micelles, dendrimers, and polymeric nanoparticles. Emphasis is placed on how these platforms enhance curcumin's bioavailability and enable targeted delivery to the brain, addressing critical challenges in AD treatment. Mechanistic insights reveal how these nanomaterials modulate key AD pathological processes, including amyloid-beta aggregation, tau phosphorylation, oxidative stress, and neuroinflammation. The review also highlighted the preclinical studies demonstrate reduced amyloid-beta plaques and neuroinflammation, alongside improved cognitive function, while clinical trials show promise in enhancing curcumin's bioavailability and efficacy in AD. Additionally, it addresses the challenges of clinical translation, such as regulatory issues, large-scale production, and long-term stability. By synthesizing recent advancements, this review underscores the potential of curcumin-loaded polymeric nanomaterials to offer a novel and effective therapeutic approach for AD, aiming to guide future research and development in this field., Competing Interests: Declaration of Competing Interest The authors declare no conflict of interest., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
16. Clinical and microbiologic effect of local application of curcumin as an adjunct to scaling and root planing in periodontitis: Systematic review.
- Author
-
Chaubal TV, Ywen BS, Ying Ying T, and Bapat R
- Subjects
- Humans, Curcumin therapeutic use, Curcumin administration & dosage, Root Planing methods, Periodontitis therapy, Periodontitis drug therapy, Periodontitis microbiology, Dental Scaling methods
- Abstract
Background: The main aim of periodontal therapy is to halt the progression of periodontitis. Curcumin, one of the main components of Curcumin longa, has been well known to possess antimicrobial, anti-inflammatory, and even anticarcinogenic properties. This systematic review assessed the impact of local application of curcumin in the pocket on the clinical and microbiologic parameters as an adjunct to scaling and root planing in periodontitis patients., Methods: The electronic literature search retrieved 61 studies from PubMed, MEDLINE, and ScienceDirect. After screening titles, abstracts, and keywords and reading through these articles, we identified 9 articles meeting all inclusion criteria, which were included for systematic review., Results: There was a significant difference in both clinical parameters in a short duration of a month after curcumin chips were placed as an adjunct to scaling and root planing as compared to the control. Local application of curcumin also results in slight to significant reduction in the red complex microorganisms., Conclusion: This review suggested that local application of curcumin can be considered as a viable adjunct to mechanical debridement in periodontitis. However, further studies need to be conducted to establish its optimum dose, delivery method, and frequency in achieving the best clinical outcomes., (© 2024. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland.)
- Published
- 2024
- Full Text
- View/download PDF
17. Polyvinylpyrrolidone-curcumin nanoparticles with immune regulatory and metabolism regulatory effects for the treatment of experimental autoimmune uveitis.
- Author
-
Cao F, Liang K, Tang WW, Ni QY, Ji ZY, Zha CK, Wang YK, Jiang ZX, Hou S, Tao LM, and Wang X
- Subjects
- Animals, Humans, Cell Line, Retinal Pigment Epithelium drug effects, Retinal Pigment Epithelium metabolism, Rats, Female, Rats, Inbred Lew, Blood-Retinal Barrier drug effects, Blood-Retinal Barrier metabolism, Male, Curcumin administration & dosage, Curcumin pharmacology, Curcumin chemistry, Curcumin therapeutic use, Uveitis drug therapy, Uveitis immunology, Uveitis metabolism, Povidone chemistry, Povidone administration & dosage, Nanoparticles administration & dosage, Nanoparticles chemistry, Autoimmune Diseases drug therapy, Oxidative Stress drug effects
- Abstract
Uveitis comprises a cluster of intraocular inflammatory disorders characterized by uncontrolled autoimmune responses and excessive oxidative stress leading to vision loss worldwide. In the present study, curcumin (CUR) was conjugated with polyvinylpyrrolidone (PVP) to form PVP-CUR nanoparticles with significantly elevated solubility and outstanding multiple radical scavenging abilities. In vitro studies revealed that PVP-CUR nanoparticles markedly mitigated oxidative stress and reduced apoptosis in a H
2 O2 -induced human retinal pigment epithelial cell line (ARPE-19) and promoted phenotypic polarization from M1 to M2 in an LPS-induced human microglial cell line (HMC3). Further in vivo studies demonstrated the prominent therapeutic effects of PVP-CUR nanoparticles on experimental autoimmune uveitis (EAU), which relieved clinical and pathological progression, improved perfusion and tomographic manifestations of retinal vessels, and reduced blood-retinal barrier (BRB) leakage; these effects may be mediated by mitigating oxidative stress and attenuating macrophage/microglia-elicited inflammation. Notably, treatment with PVP-CUR nanoparticles was shown to regulate metabolite alterations in EAU rats, providing novel insights into the underlying mechanisms involved. Additionally, the PVP-CUR nanoparticles showed great biocompatibility in vivo. In summary, our study revealed that PVP-CUR nanoparticles may serve as effective and safe nanodrugs for treating uveitis and other oxidative stress- and inflammation-related diseases., Competing Interests: Declaration of competing interest The authors declare no competing financial interest., (Copyright © 2024. Published by Elsevier B.V.)- Published
- 2024
- Full Text
- View/download PDF
18. Effect of curcumin supplementation on symptoms of anxiety: A systematic review and meta-analysis of randomized controlled trials.
- Author
-
Fathi S, Agharloo S, Falahatzadeh M, Bahraminavid S, Homayooni A, Faghfouri AH, Shafiei D, and Shafagh SG
- Subjects
- Humans, Anti-Anxiety Agents therapeutic use, Anxiety Disorders drug therapy, Curcumin therapeutic use, Randomized Controlled Trials as Topic, Anxiety drug therapy, Dietary Supplements
- Abstract
Background and Aim: Curcumin is a polyphenolic natural compound that has been used to treat various ailments such as symptoms of anxiety. However, the findings of studies regarding the anti-anxiety properties of curcumin are controversial. This review aims to evaluate if there are clinical benefits of curcumin in patients with symptoms of anxiety., Methods: PubMed, Embase, Web of Science, and the Cochrane Library were retrieved to collect randomized controlled trials (RCTs) from the database inception to August 16, 2023. The random-effects model was used to estimate the standard mean difference (SMD)., Results: A total of eight RCTs involving 567 participants were included in the analysis. A pooled analysis showed a significant effect of curcumin on anxiety symptoms (SMD: -1.56; 95% CI: -2.48, -0.64, p < 0.001; I
2 = 95.6%, p-heterogeneity< 0.001)., Conclusion: Present meta-analysis demonstrated that curcumin intake might contribute to alleviation of anxiety disorder. Due to the limited number of studies included, it is necessary to conduct more high-quality studies to confirm the clinical efficacy of curcumin., Competing Interests: Declaration of competing interest None., (Copyright © 2024 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
19. The effectiveness of curcumin as a safe agent on hearing threshold improvement in patients with chronic kidney disease: a double-blind, placebo-controlled trial.
- Author
-
Doostkam A, Iravani K, Malekmakan L, Gholamabbas G, Roozbeh J, and Soltaniesmaeili A
- Subjects
- Humans, Male, Female, Middle Aged, Double-Blind Method, Aged, Evoked Potentials, Auditory, Brain Stem drug effects, Hearing Loss drug therapy, Adult, Treatment Outcome, Curcumin therapeutic use, Renal Insufficiency, Chronic drug therapy, Renal Insufficiency, Chronic complications, Renal Insufficiency, Chronic physiopathology, Auditory Threshold drug effects
- Abstract
Hearing impairment in patients with chronic kidney disease (CKD), can affect the quality of life. At present, hearing dysfunction does not have an approved pharmacologic therapy. This study aimed to investigate the protective effects and possible mechanisms of curcumin as a therapeutic agent on hearing impairment in patients with chronic kidney disease. We conducted a randomized controlled trial of 40 chronic kidney disease patients not on dialysis with hearing impairment. Participants were randomly divided into two groups. One group received curcumin daily and the other received a placebo for 12 weeks. The interval between III and V waves, latency of wave V, auditory brain stem response (ABR) threshold, speech reception threshold (SRT), and speech discrimination score (SDS) were evaluated and analyzed before and after the intervention. After treatment, in the curcumin group, III-V waves interval and the latency of wave V were significantly reduced (P value < 0.0001), also ABR threshold was demonstrated a significant improvement (P value < 0.0001). In the trial group, the SDS was increased (P = 0.001) and the SRT was attenuated (P < 0.0001). We had either significant deterioration due to the course of the disease or insignificant changes in the placebo group. Daily administration of curcumin, can significantly improve hearing impairment in CKD patients. Accordingly, curcumin should be considered as a therapeutic option for treating hearing impairment in patients with chronic kidney disease., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
20. The Effect of Curcumin on Reducing Atherogenic Risks in Obese Patients with Type 2 Diabetes: A Randomized Controlled Trial.
- Author
-
Yaikwawong M, Jansarikit L, Jirawatnotai S, and Chuengsamarn S
- Subjects
- Humans, Male, Female, Double-Blind Method, Middle Aged, Biomarkers blood, Adult, Pulse Wave Analysis, C-Reactive Protein analysis, C-Reactive Protein metabolism, Cholesterol, LDL blood, Diabetes Mellitus, Type 2 drug therapy, Diabetes Mellitus, Type 2 complications, Diabetes Mellitus, Type 2 blood, Curcumin administration & dosage, Curcumin therapeutic use, Curcumin pharmacology, Obesity complications, Obesity drug therapy, Atherosclerosis prevention & control, Atherosclerosis etiology
- Abstract
Curcumin, derived from turmeric root, exhibits notable anti-inflammatory effects. These anti-inflammatory properties might also provide advantages in reducing cardiovascular complications, such as atherosclerosis. This study aimed to evaluate the efficacy of curcumin in reducing the risk of atherogenesis in obese patients with type 2 diabetes. The study employed a randomized, double-blind, placebo-controlled trial design with 227 participants diagnosed with type 2 diabetes. The parameters used to assess atherogenic risk reduction included pulse wave velocity and metabolic profiles, including low-density lipoprotein cholesterol and small dense low-density lipoprotein cholesterol. Measurements were recorded at baseline and at 3-, 6-, 9-, and 12-month intervals. After 12 months, participants receiving curcumin exhibited a significant reduction in pulse wave velocity ( p < 0.001). This group showed significantly reduced levels of cardiometabolic risk biomarkers, including low-density lipoprotein cholesterol and small dense low-density lipoprotein cholesterol, all with p values less than 0.001. High-sensitivity C-reactive protein, interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha were also significantly lower in the curcumin group, with p values less than 0.001. The curcumin intervention significantly reduced pulse wave velocity and improved cardiometabolic risk profiles. These findings suggest that curcumin treatment may effectively reduce atherogenic risks in type 2 diabetes patients with obesity.
- Published
- 2024
- Full Text
- View/download PDF
21. Curcumin Reduces Depression in Obese Patients with Type 2 Diabetes: A Randomized Controlled Trial.
- Author
-
Yaikwawong M, Jansarikit L, Jirawatnotai S, and Chuengsamarn S
- Subjects
- Humans, Male, Double-Blind Method, Female, Middle Aged, Malondialdehyde blood, Oxidative Stress drug effects, Serotonin metabolism, Serotonin blood, Antidepressive Agents therapeutic use, Antidepressive Agents pharmacology, Adult, Glutathione Peroxidase blood, Glutathione Peroxidase metabolism, Superoxide Dismutase blood, Superoxide Dismutase metabolism, Cytokines blood, Curcumin pharmacology, Curcumin therapeutic use, Diabetes Mellitus, Type 2 complications, Diabetes Mellitus, Type 2 drug therapy, Obesity complications, Obesity drug therapy, Depression drug therapy, Depression etiology, Antioxidants, Biomarkers blood
- Abstract
Type 2 diabetes and depression co-occur in a bidirectional manner. Curcumin supplements exhibit antidepressant effects that may mitigate depression by modulating neurotransmitters and reducing inflammatory and oxidative stress pathways. This study aimed to evaluate the efficacy of curcumin in improving depression severity in obese type 2 diabetes patients. The study employed a randomized, double-blind, placebo-controlled trial design with 227 participants. The primary end-point was depression severity assessed using the Patient Health Questionnaire-9. Biomarkers were measured at baseline and at 3-, 6-, 9-, and 12-month intervals. The biomarkers assessed were serotonin levels, pro-inflammatory cytokines (interleukin-1 beta, interleukin-6, tumor necrosis factor-alpha), antioxidant activities (total antioxidant status, glutathione peroxidase, and superoxide dismutase), and malondialdehyde. After 12 months, the curcumin group exhibited significantly improved depression severity ( p = 0.000001). The curcumin group had higher levels of serotonin ( p < 0.0001) but lower levels of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha ( p < 0.001 for all) than the placebo group. Total antioxidant status, glutathione peroxidase activity, and superoxide dismutase activity were elevated in the curcumin group, whereas malondialdehyde levels were greater in the placebo group ( p < 0.001 for all). These findings suggest curcumin may have antidepressant effects on obese type 2 diabetes patients.
- Published
- 2024
- Full Text
- View/download PDF
22. Curcumin attenuates lupus nephritis by inhibiting neutrophil migration via PI3K/AKT/NF-κB signalling pathway.
- Author
-
Yang H, Zhang H, Tian L, Guo P, Liu S, Chen H, and Sun L
- Subjects
- Animals, Mice, Female, Disease Models, Animal, Mice, Inbred MRL lpr, Kidney drug effects, Kidney pathology, Curcumin pharmacology, Curcumin therapeutic use, Lupus Nephritis drug therapy, Lupus Nephritis pathology, Lupus Nephritis metabolism, Lupus Nephritis immunology, NF-kappa B metabolism, Signal Transduction drug effects, Proto-Oncogene Proteins c-akt metabolism, Neutrophils drug effects, Neutrophils metabolism, Neutrophils immunology, Phosphatidylinositol 3-Kinases metabolism, Cell Movement drug effects
- Abstract
Objective: To investigate the role of curcumin in the treatment of lupus nephritis (LN) by inhibiting the migration of neutrophils and the underlying mechanism involved., Methods: Two lupus mouse models, MRL/lpr mice and R848-treated mice, were treated with 50 mg/kg curcumin by intraperitoneal injection. H&E and Masson staining were used to estimate histopathological changes in the kidney. Immunofluorescence was used to assess the deposition of immune complexes. The expression of inflammatory factors was detected by enzyme-linked immunosorbent assay (ELISA) and real-time reverse transcription polymerase reaction (RT-PCR), and the protein expression was detected by western blotting., Results: We revealed the remarkable potential of curcumin in improving inflammatory conditions in both MRL/lpr mice and R848-induced lupus mice. Curcumin effectively decelerates the progression of inflammation and diminishes the infiltration of neutrophils and their release of pivotal inflammatory factors, thereby reducing inflammation in renal tissues. Mechanistically, curcumin significantly inhibits the expression of p-PI3K, p-AKT and p-NF-κB, which are upregulated by interleukin-8 to induce neutrophil migration and renal inflammation, thereby reducing neutrophil migration and the release of inflammatory factors., Conclusion: Curcumin significantly inhibits the recruitment of neutrophils and the release of proinflammatory factors in the kidney by inhibiting the PI3K/AKT/NF-κB signalling pathway, providing new therapeutic targets and medication strategies for the treatment of LN., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
23. Meta-analysis of the effect of curcumin supplementation on skeletal muscle damage status.
- Author
-
Liu X, Lin L, and Hu G
- Subjects
- Humans, Range of Motion, Articular drug effects, Curcumin pharmacology, Curcumin administration & dosage, Curcumin therapeutic use, Muscle, Skeletal drug effects, Muscle, Skeletal injuries, Muscle, Skeletal metabolism, Dietary Supplements, Myalgia drug therapy, Creatine Kinase blood, Interleukin-6 blood, Interleukin-6 metabolism
- Abstract
Objectives: Meta-analysis was conducted to examine the effect of supplemental curcumin intake on skeletal muscle injury status and to propose an optimal intervention program., Methods: In accordance with the procedures specified in the PRISMA statement for systematic reviews and meta-analyses of randomized controlled trials, the Review Manager 5.3 was used to analyze the results of creatine kinase (CK), muscle soreness, interleukin-6 (IL-6), and range of motion (ROM) as outcome indicators in the 349 subjects included in the 14 articles., Results: The effect size of curcumin supplementation on muscle soreness, mean difference (MD) = -0.61; the relationship between curcumin supplementation and muscle soreness for time of measurement (I2 = 83.6%)、the relationship between curcumin supplementation and muscle soreness for period of intervention (I2 = 26.2%)、the relationship between whether one had been trained (I2 = 0%) and supplementation dose (I2 = 0%) were not heterogeneous for the relationship between curcumin supplementation and muscle soreness; The effect size on CK, MD = -137.32; the relationship between curcumin supplementation and CK (I2 = 79.7%)、intervention period (I2 = 91.9%)、whether or not trained (I2 = 90.7%)、and no heterogeneity in the relationship between curcumin supplementation and CK for the time of measurement (I2 = 0%); The effect size MD = 4.10 for the effect on ROM; The effect size for IL-6 was MD = -0.33., Conclusions: This meta-analysis highlights that curcumin supplementation significantly mitigates skeletal muscle damage, with notable improvements in CK levels, muscle soreness, IL-6 levels, and ROM. The results highlight the importance of curcumin dosage and timing, revealing that prolonged supplementation yields the best results, especially for untrained individuals or those less exposed to muscle-damaging exercise. For muscle soreness and ROM enhancement, a pre-emptive, low-dose regimen is beneficial, while immediate post-exercise supplementation is most effective at reducing CK and IL-6 levels., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Liu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
24. Curcumin and Gut Microbiota: A Narrative Overview with Focus on Glycemic Control.
- Author
-
Servida S, Piontini A, Gori F, Tomaino L, Moroncini G, De Gennaro Colonna V, La Vecchia C, and Vigna L
- Subjects
- Humans, Animals, Dysbiosis microbiology, Hypoglycemic Agents therapeutic use, Hypoglycemic Agents pharmacology, Gastrointestinal Microbiome drug effects, Curcumin therapeutic use, Curcumin pharmacology, Glycemic Control methods, Diabetes Mellitus, Type 2 drug therapy, Diabetes Mellitus, Type 2 metabolism, Diabetes Mellitus, Type 2 microbiology
- Abstract
Turmeric is a spice widely used in China, Southeast Asia, and in traditional Ayurvedic medicine. Its safety profile and efficacy as an antioxidant, anti-inflammatory, antimicrobial, antitumor, antidiabetic, and anti-obesity agent have led to extensive research into its potential role in preventing and treating metabolic diseases. The active compound in turmeric is curcumin, which exhibits low systemic bioavailability after oral administration. However, it is detectable in the gut, where it bidirectionally interacts with the gut microbiota (GM), which plays a crucial role in maintaining host health. The favorable effects of curcumin, particularly its hypoglycemic properties, are linked to alteration in intestinal dysbiosis observed in type 2 diabetes mellitus and metabolic syndrome patients. Restoration of the eubiotic GM may contribute to glycemic homeostasis. Preclinical and clinical studies have demonstrated the involvement of the GM in the regulation of glucose and lipid metabolism. Although the underlying mechanism remains incompletely understood, intestinal dysbiosis is associated with insulin resistance, hyperglycemia, and low-grade inflammation. In the present overview, we summarize the biological properties of curcumin, focusing on its link with GM and, therefore, on its potential role in metabolic diseases.
- Published
- 2024
- Full Text
- View/download PDF
25. Epigallocatechin gallate and curcumin inhibit Bcl-2: a pharmacophore and docking based approach against cancer.
- Author
-
Bahadar N, Bahadar S, Sajid A, Wahid M, Ali G, Alghamdi A, Zada H, Khan T, Ullah S, and Sun Q
- Subjects
- Humans, Antineoplastic Agents pharmacology, Antineoplastic Agents therapeutic use, Antineoplastic Agents chemistry, Neoplasms drug therapy, Neoplasms pathology, Neoplasms metabolism, Protein Binding, Pharmacophore, Catechin analogs & derivatives, Catechin pharmacology, Catechin chemistry, Catechin therapeutic use, Molecular Docking Simulation, Proto-Oncogene Proteins c-bcl-2 antagonists & inhibitors, Proto-Oncogene Proteins c-bcl-2 metabolism, Curcumin pharmacology, Curcumin chemistry, Curcumin therapeutic use
- Abstract
The protein Bcl-2, well-known for its anti-apoptotic properties, has been implicated in cancer pathogenesis. Identifying the primary gene responsible for promoting improved cell survival and development has provided compelling evidence for preventing cellular death in the progression of malignancies. Numerous research studies have provided evidence that the abundance of Bcl-2 is higher in malignant cells, suggesting that suppressing Bcl-2 expression could be a viable therapeutic approach for cancer treatment. In this study, we acquired a compound collection using a database that includes constituents from Traditional Chinese Medicine (TCM). Initially, we established a pharmacophore model and utilized it to search the TCM database for potential compounds. Compounds with a fitness score exceeding 0.75 were selected for further analysis. The Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) analysis identified six compounds with favorable therapeutic characteristics. The compounds that successfully passed the initial screening process based on the pharmacodynamic model were subjected to further evaluation. Extra-precision (XP) docking was employed to identify the compounds with the most favorable XP docking scores. Further analysis using the Molecular Mechanics Generalized Born Surface Area (MM-GBSA) method to calculate the overall free binding energy. The binding energy between the prospective ligand molecule and the target protein Bcl-2 was assessed by a 100 ns molecular dynamics simulation for curcumin and Epigallocatechin gallate (EGCG). The findings of this investigation demonstrate the identification of a molecular structure that effectively inhibits the functionality of the Bcl-2 when bound to the ligand EGCG. Consequently, this finding presents a novel avenue for the development of pharmaceuticals capable of effectively addressing both inflammatory and tumorous conditions., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
26. Curcumin is effective in managing oral inflammation: An in vitro study.
- Author
-
Idrees M and Kujan O
- Subjects
- Humans, Cell Line, Wound Healing drug effects, Anti-Inflammatory Agents therapeutic use, Anti-Inflammatory Agents pharmacology, Candida albicans drug effects, Lipopolysaccharides, In Vitro Techniques, Periodontal Ligament cytology, Periodontal Ligament drug effects, Gels, Inflammation drug therapy, Apoptosis drug effects, Stomatitis drug therapy, Cell Adhesion drug effects, Curcumin pharmacology, Curcumin therapeutic use, Keratinocytes drug effects, Fibroblasts drug effects, Porphyromonas gingivalis drug effects, Cell Proliferation drug effects, Streptococcus mutans drug effects
- Abstract
Background: Oral inflammation is among the most prevalent oral pathologies with systemic health implications, necessitating safe and effective treatments. Given curcumin's documented anti-inflammatory and antioxidant properties, this study focuses on the potential of a curcumin-based oral gel in safely managing oral inflammatory conditions., Methods: This in vitro study utilized four human cell lines: oral keratinocytes (HOKs), immortalized oral keratinocytes (OKF6), periodontal ligament fibroblasts (HPdLF), and dysplastic oral keratinocytes (DOKs). The cells were treated with Lipopolysaccharides (LPS) and curcumin-based oral gel to simulate inflammatory conditions. A panel of cellular assays were performed along with antimicrobial efficacy tests targeting Candida albicans, Streptococcus mutans, and Porphyromonas gingivalis., Results: LPS significantly reduced proliferation and wound healing capacities of HOKs, OKF6, and HPdLF, but not DOKs. Treatment with curcumin-based oral gel mitigated inflammatory responses in HOKs and HPdLF by enhancing proliferation, colony formation, and wound healing, along with reducing apoptosis. However, its impact on OKF6 and DOKs was limited in some assays. Curcumin treatment did not affect the invasive capabilities of any cell line but did modulate cell adhesion in a cell line-specific manner. The curcumin-based oral gel showed significant antimicrobial efficacy against C. albicans and S. mutans, but was ineffective against P. gingivalis., Conclusion: This study demonstrates the potential of the curcumin-based oral gel as a safe and effective alternative to conventional antimicrobial treatments for managing cases of oral inflammation. This was achieved by modulating cellular responses under simulated inflammatory conditions. Future clinical-based studies are recommended to exploit curcumin's therapeutic benefits in oral healthcare., (© 2024 The Authors. Journal of Oral Pathology & Medicine published by John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
27. Curcumin Equipped Nanozyme-Like Metal-Organic Framework Platform for the Targeted Atherosclerosis Treatment with Lipid Regulation and Enhanced Magnetic Resonance Imaging Capability.
- Author
-
Lv F, Fang H, Huang L, Wang Q, Cao S, Zhao W, Zhou Z, Zhou W, and Wang X
- Subjects
- Animals, Mice, Disease Models, Animal, Macrophages metabolism, Macrophages drug effects, Humans, Curcumin pharmacology, Curcumin therapeutic use, Metal-Organic Frameworks chemistry, Atherosclerosis diagnostic imaging, Atherosclerosis drug therapy, Atherosclerosis metabolism, Magnetic Resonance Imaging methods
- Abstract
Atherosclerotic cardiovascular disease (ASCVD) has become the leading cause of death worldwide, and early diagnosis and treatment of atherosclerosis (AS) are crucial for reducing the occurrence of acute cardiovascular events. However, early diagnosis of AS is challenging, and oral anti-AS drugs suffer from limitations like imprecise targeting and low bioavailability. To overcome the aforementioned shortcomings, Cur/MOF@DS is developed, a nanoplatform integrating diagnosis and treatment by loading curcumin (Cur) into metal-organic frameworks with nanozymes and magnetic resonance imaging (MRI) properties. In addition, the surface-modification of dextran sulfate (DS) enables PCN-222(Mn) effectively target scavenger receptor class A in macrophages or foam cells within the plaque region. This nanoplatform employs mechanisms that effectively scavenge excessive reactive oxygen species in the plaque microenvironment, promote macrophage autophagy and regulate macrophage polarization to realize lipid regulation. In vivo and in vitro experiments confirm that this nanoplatform has outstanding MRI performance and anti-AS effects, which may provide a new option for early diagnosis and treatment of AS., (© 2024 The Authors. Advanced Science published by Wiley‐VCH GmbH.)
- Published
- 2024
- Full Text
- View/download PDF
28. Hexahydrocurcumin Attenuates Neuronal Injury and Modulates Synaptic Plasticity in Chronic Cerebral Hypoperfusion in Rats.
- Author
-
Jearjaroen P, Thangwong P, Tocharus C, Lungkaphin A, Chaichompoo W, Srijun J, Suksamrarn A, and Tocharus J
- Subjects
- Animals, Male, Rats, Brain Ischemia drug therapy, Brain Ischemia metabolism, Brain Ischemia pathology, tau Proteins metabolism, Brain-Derived Neurotrophic Factor metabolism, NF-E2-Related Factor 2 metabolism, Amyloid beta-Peptides metabolism, Neuroprotective Agents pharmacology, Neuroprotective Agents therapeutic use, Chronic Disease, Curcumin pharmacology, Curcumin analogs & derivatives, Curcumin therapeutic use, Neuronal Plasticity drug effects, Rats, Sprague-Dawley, Neurons drug effects, Neurons metabolism, Oxidative Stress drug effects
- Abstract
Dementia is the most common age-related problem due predominantly to Alzheimer's disease (AD) and vascular dementia (VaD). It has been shown that these contributors are associated with a high amount of oxidative stress that leads to changes in neurological function and cognitive impairment. The aim of study was to explore the mechanism by which hexahydrocurcumin (HHC) attenuates oxidative stress, amyloidogenesis, phosphorylated Tau (pTau) expression, neuron synaptic function, and cognitive impairment and also the potential mechanisms involved in induced permanent occlusion of bilateral common carotid arteries occlusion (BCCAO) or 2-vessel occlusion (2VO) in rats. After surgery, rats were treated with HHC (40 mg/kg) or piracetam (600 mg/kg) by oral gavage daily for 4 weeks. The results showed that HHC or piracetam attenuated oxidative stress by promoting nuclear factor erythroid 2-related factor 2 (Nrf2) activity, and alleviated expression of synaptic proteins (pre- and post-synaptic proteins) mediated by the Wingless/Integrated (Wnt)/β-catenin signaling pathway. Moreover, HHC or piracetam also improved synaptic plasticity via the brain-derived neurotrophic factor (BDNF)/Tyrosine receptor kinase B (TrkB)/cAMP responsive element binding protein (CREB) signaling pathway. In addition, HHC reduced amyloid beta (Aβ) production and pTau expression and improved memory impairment as evidenced by the Morris water maze. In conclusion, HHC exerted remarkable improvement in cognitive function in the 2VO rats possibly via the attenuation of oxidative stress, improvement in synaptic function, attenuation of amyloidogenesis, pTau, and neuronal injury, thereby improving cognitive performance., (© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
29. The efficacy of curcumin supplementation on serum total antioxidant capacity, malondialdehyde, and disease activity in women with rheumatoid arthritis: A randomized, double-blind, placebo-controlled clinical trial.
- Author
-
Pourhabibi-Zarandi F, Rafraf M, Zayeni H, Asghari-Jafarabadi M, and Ebrahimi AA
- Subjects
- Humans, Female, Double-Blind Method, Middle Aged, Adult, Oxidative Stress drug effects, Curcumin pharmacology, Curcumin therapeutic use, Arthritis, Rheumatoid drug therapy, Arthritis, Rheumatoid blood, Malondialdehyde blood, Antioxidants, Dietary Supplements
- Abstract
Oxidative stress plays a crucial role in the physiopathology of rheumatoid arthritis (RA), which is associated with impaired antioxidant defenses. This study aimed to investigate the effects of curcumin supplementation on serum levels of total antioxidant capacity (TAC), malondialdehyde (MDA), and disease activity in women with RA. In this clinical trial, 48 women with RA were treated with one capsule of curcumin (500 mg daily) or placebo for 8 weeks. Anthropometric measurements and fasting blood samples were collected at baseline and end of the study. Finally, we assessed the Disease Activity Score in 28 joints (DAS-28), dietary intake, and physical activity levels. While curcumin supplementation for 8 weeks significantly increased the serum levels of TAC (p < 0.05), it decreased tender joint counts, swollen joint counts, visual analog scale (VAS) for pain, and DAS-28 compared to the placebo at the end of the study (p < 0.001 for all). MDA levels significantly decreased in the curcumin group (p < 0.05). However, changes in MDA concentration were not significant between groups at the end of the trial (p = 0.145). Curcumin supplementation had a beneficial effect on increasing the serum levels of TAC and decreased DAS-28 in women with RA., (© 2024 John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
30. Therapeutic potential of curcumin on the cognitive decline in animal models of Alzheimer's disease: a systematic review and meta-analysis.
- Author
-
Fan L and Zhang Z
- Subjects
- Animals, Humans, Cognition drug effects, Cognition Disorders drug therapy, Cognition Disorders psychology, Curcumin pharmacology, Curcumin therapeutic use, Alzheimer Disease drug therapy, Alzheimer Disease psychology, Disease Models, Animal
- Abstract
Curcumin, a polyphenol derived from the herb turmeric, has emerged as a prospective potential therapy in the treatment of Alzheimer's disease (AD). However, the efficacy of curcumin treatment in improving cognitive decline caused controversy recently. We aimed to systematically review the effect of curcumin on cognitive impairment in an animal model of AD. We conducted an exhaustive database search of related studies. Two investigators identified studies and independently extracted data. Stratified meta-analyses and meta-regression analyses were carried out to explore the sources of heterogeneity. Publication bias was assessed using funnel plots and Egger's test. Our systematic review included 33 articles. A meta-analysis of 29 publications showed that curcumin exerts significant positive effects on cognitive performance. For acquisition, the global estimated effect of curcumin was - 2.027 (95% CI - 2.435 to - 1.619, p < 0.001); for retention, the global estimated effect of curcumin was 1.606 (95% CI 1.101 to 2.111, p < 0.001). The stratified meta-analysis demonstrated that an increased effect size depended on diverse study characteristics. Additionally, publication bias was detected. We conclude that curcumin may reduce cognitive deficits in experimental AD. Furthermore, we emphasize that additional well-designed and well-reported animal studies are needed to inform further clinical studies., (© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
31. Antioxidant, anti-inflammatory and epigenetic potential of curcumin in Alzheimer's disease.
- Author
-
Abdul-Rahman T, Awuah WA, Mikhailova T, Kalmanovich J, Mehta A, Ng JC, Coghlan MA, Zivcevska M, Tedeschi AJ, de Oliveira EC, Kumar A, Cantu-Herrera E, Lyndin M, Sikora K, Alexiou A, Bilgrami AL, Al-Ghamdi KM, Perveen A, Papadakis M, and Ashraf GM
- Subjects
- Humans, Animals, Neuroprotective Agents therapeutic use, Neuroprotective Agents pharmacology, Signal Transduction drug effects, Oxidative Stress drug effects, Alzheimer Disease drug therapy, Alzheimer Disease genetics, Alzheimer Disease metabolism, Alzheimer Disease pathology, Curcumin pharmacology, Curcumin therapeutic use, Epigenesis, Genetic drug effects, Antioxidants pharmacology, Antioxidants therapeutic use, Anti-Inflammatory Agents pharmacology, Anti-Inflammatory Agents therapeutic use
- Abstract
Alzheimer's disease (AD) constitutes a multifactorial neurodegenerative pathology characterized by cognitive deterioration, personality alterations, and behavioral shifts. The ongoing brain impairment process poses significant challenges for therapeutic interventions due to activating multiple neurotoxic pathways. Current pharmacological interventions have shown limited efficacy and are associated with significant side effects. Approaches focusing on the early interference with disease pathways, before activation of broad neurotoxic processes, could be promising to slow down symptomatic progression of the disease. Curcumin-an integral component of traditional medicine in numerous cultures worldwide-has garnered interest as a promising AD treatment. Current research indicates that curcumin may exhibit therapeutic potential in neurodegenerative pathologies, attributed to its potent anti-inflammatory and antioxidant properties. Additionally, curcumin and its derivatives have demonstrated an ability to modulate cellular pathways via epigenetic mechanisms. This article aims to raise awareness of the neuroprotective properties of curcuminoids that could provide therapeutic benefits in AD. The paper provides a comprehensive overview of the neuroprotective efficacy of curcumin against signaling pathways that could be involved in AD and summarizes recent evidence of the biological efficiency of curcumins in vivo., (© 2024 The Authors. BioFactors published by Wiley Periodicals LLC on behalf of International Union of Biochemistry and Molecular Biology.)
- Published
- 2024
- Full Text
- View/download PDF
32. Multifaceted physiological and therapeutical impact of curcumin on hormone-related endocrine dysfunctions: A comprehensive review.
- Author
-
Wang X, Zhang W, and Zhou S
- Subjects
- Humans, Animals, Signal Transduction drug effects, Antioxidants pharmacology, Oxidative Stress drug effects, Curcumin pharmacology, Curcumin therapeutic use, Curcuma chemistry, Endocrine System Diseases drug therapy
- Abstract
Over the past five decades, Curcumin (Cur), derived from turmeric (Curcuma longa), has gained considerable attention for its potential therapeutic applications. Synthesizing insights from clinical trials conducted over the last 25 years, this review delves into diseases where Cur has demonstrated promise, offering a nuanced understanding of its pharmacokinetics, safety, and effectiveness. Focusing on specific examples, the impact of Cur on various human diseases is explored. Endocrine glands and associated signaling pathways are highlighted, elucidating how Cur influences cellular signaling. The article underscores molecular mechanisms such as hormone level alteration, receptor interaction, cytokine and adipokine expression inhibition, antioxidant enzyme activity, and modulation of transcription factors. Cur showcases diverse protective mechanisms against inflammation and oxidative damage by suppressing antiapoptotic genes and impeding tumor promotion. This comprehensive overview emphasizes the potential of Cur as a natural agent for countering aging and degenerative diseases, calling for further dedicated research in this realm., (© 2024 John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
33. Augmenting Neutrophil Extracellular Traps with Carbonized Polymer Dots: A Potential Treatment for Bacterial Sepsis.
- Author
-
Lin CJ, Hwang TL, Wang RYL, Nain A, Shih RH, Chang L, Lin HJ, Harroun SG, Chang HT, and Huang CC
- Subjects
- Animals, Mice, Neutrophils drug effects, Carbon chemistry, Carbon pharmacology, Staphylococcal Infections drug therapy, Curcumin pharmacology, Curcumin therapeutic use, Curcumin chemistry, Humans, Sepsis drug therapy, Extracellular Traps drug effects, Polymers chemistry, Methicillin-Resistant Staphylococcus aureus drug effects
- Abstract
Sepsis is a life-threatening condition that can progress to septic shock as the body's extreme response to pathogenesis damages its own vital organs. Staphylococcus aureus (S. aureus) accounts for 50% of nosocomial infections, which are clinically treated with antibiotics. However, methicillin-resistant strains (MRSA) have emerged and can withstand harsh antibiotic treatment. To address this problem, curcumin (CCM) is employed to prepare carbonized polymer dots (CPDs) through mild pyrolysis. Contrary to curcumin, the as-formed CCM-CPDs are highly biocompatible and soluble in aqueous solution. Most importantly, the CCM-CPDs induce the release of neutrophil extracellular traps (NETs) from the neutrophils, which entrap and eliminate microbes. In an MRSA-induced septic mouse model, it is observed that CCM-CPDs efficiently suppress bacterial colonization. Moreover, the intrinsic antioxidative, anti-inflammatory, and anticoagulation activities resulting from the preserved functional groups of the precursor molecule on the CCM-CPDs prevent progression to severe sepsis. As a result, infected mice treated with CCM-CPDs show a significant decrease in mortality even through oral administration. Histological staining indicates negligible organ damage in the MRSA-infected mice treated with CCM-CPDs. It is believed that the in vivo studies presented herein demonstrate that multifunctional therapeutic CPDs hold great potential against life-threatening infectious diseases., (© 2024 Wiley‐VCH GmbH.)
- Published
- 2024
- Full Text
- View/download PDF
34. Cardioprotective effects of curcumin against Diabetic Cardiomyopathies: A systematic review and meta-analysis of preclinical studies.
- Author
-
Wang W, Chang P, Jin J, Pu F, Li D, Bai Y, Dong K, Yang Q, and Li T
- Subjects
- Animals, Apoptosis drug effects, Curcumin pharmacology, Curcumin therapeutic use, Diabetic Cardiomyopathies drug therapy, Diabetic Cardiomyopathies prevention & control, Cardiotonic Agents pharmacology, Cardiotonic Agents therapeutic use
- Abstract
Background: As a common complication of diabetes, diabetic cardiomyopathy (DCM) often leads to further damage to the heart muscle. Curcumin has been proven to have a variety of cardioprotective effects, however, the protective effect against DCM has not been systematically reviewed., Purpose: In this study, we aimed to analyze the preclinical (animal model) evidence of curcumin's therapeutic effects in DCM., Methods: Eight databases and two registry systems were searched from the time of library construction to 1 November 2023. We performed rigorous data extraction and quality assessment. The included studies' methodological quality was appraised using the SYRCLE RoB tool, statistical analyses were carried out using RevMan 5.4 software, and Funnel plots and Egger's test were performed using Stata 17.0 software to assess publication bias., Results: This study included 32 trials with a total of 681 animals. Meta-analysis showed that curcumin significantly improved cardiac function indices (LVEF, LVFS, and LVSd) (p < 0.01), decreased markers of myocardial injury, HW/BW ratio, and randomized blood glucose compared to the control group, in addition to showing beneficial effects on mechanistic indices of myocardial oxidation, inflammation, apoptosis, and autophagy (p < 0.05)., Conclusions: Curcumin may exert cardioprotective effects in DCM through its antioxidant, anti-inflammatory, autophagy-enhancing, and anti-apoptotic effects. Its protective effect is proportional to the dose, and the efficacy may be further increased at a concentration of more than 200 mg/kg, and further validation is needed., Competing Interests: Declaration of competing interest The authors declare no conflict of interest., (Copyright © 2024. Published by Elsevier GmbH.)
- Published
- 2024
- Full Text
- View/download PDF
35. Synergistic berberine chloride and Curcumin-Loaded nanofiber therapies against Methicillin-Resistant Staphylococcus aureus Infection: Augmented immune and inflammatory responses in zebrafish wound healing.
- Author
-
Kandaswamy K, Prasad Panda S, Subramanian R, Khan H, Rafi Shaik M, Althaf Hussain S, Guru A, and Arockiaraj J
- Subjects
- Animals, Drug Synergism, Molecular Docking Simulation, Cytokines metabolism, Biofilms drug effects, Humans, Anti-Inflammatory Agents pharmacology, Anti-Inflammatory Agents therapeutic use, Zebrafish, Methicillin-Resistant Staphylococcus aureus drug effects, Curcumin pharmacology, Curcumin chemistry, Curcumin therapeutic use, Berberine pharmacology, Berberine chemistry, Berberine therapeutic use, Wound Healing drug effects, Staphylococcal Infections drug therapy, Staphylococcal Infections immunology, Nanofibers chemistry, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents therapeutic use, Anti-Bacterial Agents chemistry
- Abstract
Background: Wound healing pivots on a finely orchestrated inflammatory cascade, critical for tissue repair. Chronic wounds, compounded by persistent inflammation and susceptibility to infection, pose formidable clinical challenges. Nanofiber dressings offer promising avenues for wound care, yet their interaction with inflammation and infection remains elusive. We aim to delineate the inflammatory cascade preceding wound closure and assess Cu@Bbc nanofibers' therapeutic efficacy in mitigating inflammation and combating infection. Their unique attributes suggest promise in modulating inflammation, fostering tissue regeneration, and preventing microbial colonization. Investigating the intricate interplay between nanofiber scaffolds, inflammation, and infection may unveil mechanisms of enhanced wound healing. Our findings could stimulate the development of tailored dressings, urgently needed for effective wound management amidst immune dysregulation, infection, and inflammation., Methods: In this investigation, we synthesized Cu@Bbc nanofibers, incorporating curcumin and berberine chloride, for wound healing applications. We evaluated their individual and combined antibacterial, anti-biofilm, and antioxidant activities, alongside binding affinity with pro-inflammatory cytokines through molecular docking. Morphological characterization was conducted via SEM, FTIR assessed functional groups, and wettability contact angle measured hydrophobic properties. The physical properties, including tensile strength, swelling behavior, and thermal stability, were evaluated using tensile testing, saline immersion method and thermogravimetric analysis. Biodegradability of the nanofibers was assessed through a soil burial test. Biocompatibility was determined via MTT assay, while wound healing efficacy was assessed with in vitro scratch assays. Controlled drug release and antibacterial activity against MRSA were examined, with in vivo assessment in a zebrafish model elucidating inflammatory responses and tissue remodeling., Results: In this study, the synergistic action of curcumin and berberine chloride exhibited potent antibacterial efficacy against MRSA, with significant anti-mature biofilm disruption. Additionally, the combination demonstrated heightened antioxidant potential. Molecular docking studies revealed strong binding affinity with pro-inflammatory cytokines, suggesting a role in expediting the inflammatory response crucial for wound healing. Morphological analysis confirmed nanofiber quality, with drug presence verified via FTIR spectroscopy. Cu@Bbc demonstrated higher tensile strength, optimal swelling behavior, and robust thermal stability as evaluated through tensile testing and thermogravimetric analysis. Additionally, the Cu@Bbc nanofiber showed enhanced biodegradability, as confirmed by the soil burial test. Biocompatibility assessments showed favorable compatibility, while in vitro studies demonstrated potent antibacterial activity. In vivo zebrafish experiments revealed accelerated wound closure, re-epithelialization, and heightened immune response, indicative of enhanced wound healing., Conclusion: In summary, our investigation highlights the efficacy of Cu@Bbc nanofibers, laden with curcumin and berberine chloride, in displaying robust antibacterial and antioxidant attributes while also modulating immune responses and inflammatory cascades essential for wound healing. These results signify their potential as multifaceted wound dressings for clinical implementation., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
36. Sustained Release of Liposomal Curcumin: Enhanced Periodontal Outcomes in Diabetic Patients.
- Author
-
Abdallah Khalil A and Alaaeldin E
- Subjects
- Humans, Male, Female, Middle Aged, Adult, Dental Scaling, Periodontitis drug therapy, Root Planing, Treatment Outcome, Tumor Necrosis Factor-alpha, Antioxidants therapeutic use, Antioxidants administration & dosage, Periodontal Index, Curcumin therapeutic use, Curcumin administration & dosage, Liposomes, Delayed-Action Preparations
- Abstract
Objective: To evaluate the effect of entrapment of curcumin within liposomal formulation and the sustained release attitude of the formulated liposomal gel on periodontal defects in diabetic patients in clinical and biochemical terms., Methods: Thirty diabetic patients with periodontitis were randomly assigned to three equal groups and ten healthy participants were assigned as the control group. Group I was subjected to scaling and root planing (SRP) with application of sustained release liposomal curcumin gel. Group II was subjected to scaling and root planning with application of curcumin gel. Group III was subjected to scaling and root planning with application of placebo gel. Group IV (control group), no intervention was done. The following parameters were evaluated before treatment and after 6 and 12 weeks: plaque index (PI), gingival index (GI), probing depth (PD), clinical attachment level (CAL), tumour necrosis factor alpha (TNF-α), interleukin 1 beta (IL-1β) and total antioxidant capacity (TAC)., Results: All study groups showed improvement in clinical and biochemical parameters that are statistically significant. Upon comparing the results of treatment modalities, the highest improvement was achieved in group I followed by group II then group III., Conclusion: Sustained release liposomal curcumin gel enhanced the antioxidant capacity, decreased the inflammatory mediators and showed more improvement in clinical outcome for treatment of periodontitis in diabetic patients.
- Published
- 2024
- Full Text
- View/download PDF
37. Efficacy of highly bioavailable oral curcumin in asymptomatic or mild COVID-19 patients: a double-blind, randomized, placebo-controlled trial.
- Author
-
Kishimoto A, Komiyama M, Wada H, Satoh-Asahara N, Yamakage H, Ajiro Y, Aoyama H, Katsuura Y, Imaizumi A, Hashimoto T, Sunagawa Y, Morimoto T, Kanai M, Kakeya H, and Hasegawa K
- Subjects
- Humans, Double-Blind Method, Male, Female, Middle Aged, Administration, Oral, Adult, Aged, Treatment Outcome, SARS-CoV-2, Biological Availability, Curcumin administration & dosage, Curcumin therapeutic use, Curcumin pharmacokinetics, COVID-19 Drug Treatment, COVID-19
- Abstract
Introduction: Even after the peak of the COVID-19 pandemic, the number of mild cases remains high, requiring continuous control. Curcumin, owing to its anti-inflammatory properties, can suppress vital proliferation and cytokine secretion in animal models. We developed a highly absorbable curcumin, curcuRouge
® (cR), which is approximately 100 times more orally bioavailable than conventional curcumin. We evaluated the effect of cR on the inhibition of disease progression in asymptomatic or mildly symptomatic COVID-19 patients., Methods: This study evaluated the effect of 7-day oral intake of cR (360 mg twice daily). Patients within 5 days of COVID-19 diagnosis were randomly assigned to a placebo or cR group in a double-blind manner., Results: Primary endpoint events [body temperature (BT) ≥ 37.5 °C and saturation of percutaneous oxygen (SpO2) < 96%] were fewer than expected, and the rate of these events was 2.8% in the cR group (2/71) and 6.0% in the placebo group (4/67); hazard ratio (HR) = 0.532, 95% confidence interval (CI) 0.097-2.902. Patients receiving cR tended to take fewer antipyretic medications than those receiving placebo (HR = 0.716, 95% CI 0.374-1.372). Among patients with a normal range of BT at baseline, the BT change rate was significantly (p = 0.014) lower in the cR group (- 0.34%) versus placebo (- 0.01%)., Conclusion: The relative suppression of event rates and antipyretic medications taken, and significant decrease of subclinical BT support the anti-inflammatory effects of cR in asymptomatic or mildly symptomatic patients with COVID-19., Trial Registration: Japan Registry of Clinical Trials (CRB5200002)., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
38. Ameliorative Effects of Curcumin on Type 2 Diabetes Mellitus.
- Author
-
Gu Y, Niu Q, Zhang Q, and Zhao Y
- Subjects
- Humans, Animals, Antioxidants pharmacology, Antioxidants therapeutic use, Anti-Inflammatory Agents pharmacology, Anti-Inflammatory Agents therapeutic use, Curcumin pharmacology, Curcumin therapeutic use, Diabetes Mellitus, Type 2 drug therapy, Hypoglycemic Agents pharmacology, Hypoglycemic Agents therapeutic use
- Abstract
Type 2 diabetes mellitus (T2DM), a multifactorial and complicated metabolic disorder, is a growing public health problem. Numerous studies have indicated that bioactive compounds from herbal medicine have beneficial effects on T2DM prevention and treatment, owing to their numerous biological properties. Curcumin, the major curcuminoid of turmeric, is one of the most studied bioactive components of herbal supplements, and has a variety of biological activities. Clinical trials and preclinical research have recently produced compelling data to demonstrate the crucial functions of curcumin against T2DM via several routes. Accordingly, this review systematically summarizes the antidiabetic activity of curcumin, along with various mechanisms. Results showed that effectiveness of curcumin on T2DM is due to it being anti-inflammatory, anti-oxidant, antihyperglycemic, anti-apoptotic, and antihyperlipidemic, among other activities. In light of these results, curcumin may be a promising prevention/treatment choice for T2DM.
- Published
- 2024
- Full Text
- View/download PDF
39. Curcumin as a Potential Therapeutic Agent for Mitigating Carbon Monoxide Poisoning: Evidence from an Experimental Rat Study.
- Author
-
Doğan G, Kayır S, Ayaz E, Özcan O, and Akdağlı Ekici A
- Subjects
- Animals, Female, Rats, Hippocampus metabolism, Hippocampus drug effects, Arginine pharmacology, Arginine metabolism, Arginine analogs & derivatives, Carbon Monoxide metabolism, Antioxidants pharmacology, Antioxidants metabolism, Proto-Oncogene Proteins c-bcl-2 metabolism, Curcumin pharmacology, Curcumin therapeutic use, Carbon Monoxide Poisoning drug therapy, Carbon Monoxide Poisoning metabolism, Malondialdehyde metabolism, Rats, Sprague-Dawley, Nitric Oxide metabolism, Superoxide Dismutase metabolism, Oxidative Stress drug effects, Catalase metabolism
- Abstract
BACKGROUND Carbon monoxide (CO) is a poisonous gas and causes tissue damage through oxidative stress. We aimed to investigate the protective value of curcumin in CO poisoning. MATERIAL AND METHODS Twenty-four female Spraque Dawley rats were divided into 4 subgroups: controls (n=6), curcumin group (n=6), CO group (n=6), and curcumin+CO group (n=6). The experimental group was exposed to 3 L/min of CO gas at 3000 ppm. Curcumin was administered intraperitoneally at a dosage of 50 mg/kg. Hippocampal tissues were removed and separated for biochemical and immunohistochemical analysis. Tissue malondialdehyde (MDA) levels, nitric oxide (NO) levels, and superoxide dismutase (SOD) and catalase (CAT) activities were assayed spectrophotometrically, and serum asymmetric dimethylarginine (ADMA) were measured using the ELISA technique. Tissue Bcl-2 levels were detected by the immunohistochemistry method. RESULTS Tissue CAT and SOD activities and NO levels were significantly lower, and MDA and serum ADMA levels were higher in the CO group than in the control group (P<0.001). The curcumin+CO group had higher CAT activities (P=0.007) and lower MDA than the CO group (P<0.001) and higher ADMA levels than the control group (P=0.023). However, there was no significant difference observed for tissue SOD activity or NO levels between these 2 groups. In the curcumin+CO group, the Bcl-2 level was higher than that in the CO group (P=0.017). CONCLUSIONS The positive effect of curcumin on CAT activities, together with suppression of MDA levels, has shown that curcumin may have a protective effect against CO poisoning.
- Published
- 2024
- Full Text
- View/download PDF
40. Exploring Curcumin-Loaded Lipid-Based Nanomedicine as Efficient Targeted Therapy for Alzheimer's Diseases.
- Author
-
Far BF, Safaei M, Pourmolaei A, Adibamini S, Shirdel S, Shirdel S, Emadi R, and Kaushik AK
- Subjects
- Humans, Animals, Particle Size, Biocompatible Materials chemistry, Biocompatible Materials pharmacology, Nanoparticles chemistry, Materials Testing, Drug Delivery Systems, Amyloid beta-Peptides metabolism, Amyloid beta-Peptides antagonists & inhibitors, Curcumin chemistry, Curcumin pharmacology, Curcumin therapeutic use, Alzheimer Disease drug therapy, Alzheimer Disease metabolism, Nanomedicine, Lipids chemistry
- Abstract
Alzheimer's disease (AD) is a neurological condition currently with 47 million people suffering from it globally. AD might have many reasons such as genetic issues, environmental factors, and Aβ accumulation, which is the biomarker of the disease. Since the primary reason is unknown, there is no targeted treatment at the moment, but ongoing research aims to slow its progression by managing amyloid-beta peptide production rather than symptomatic improvement. Since phytochemicals have been demonstrated to possess antioxidant, anti-inflammatory, and neuroprotective properties, they may target multiple pathological factors and can reduce the risk of the disease. Curcumin, as a phytochemical found in turmeric known for its antioxidant, free radical scavenging properties, and as an antiamyloid in treating AD, has come under investigation. Although its low bioavailability limits its efficacy, a prominent drug delivery system (DDS) is desired to overcome it. Hence, the potency of lipid-based nanoparticles encapsulating curcumin (LNPs-CUR) is considered in this study as a promising DDS. In vivo studies in animal models indicate LNPs-CUR effectively slow amyloid plaque formation, leading to cognitive enhancement and reduced toxicity compared to free CUR. However, a deeper understanding of CUR's pharmacokinetics and safety profile is crucial before LNPs-CUR can be considered as a medicine. Future investigations may explore the combination of NPs with other therapeutic agents to increase their efficacy in AD cases. This review provides the current position of CUR in the AD therapy paradigm, the DDS suggestions for CUR, and the previous research from the point of analytical view focused on the advantages and challenges.
- Published
- 2024
- Full Text
- View/download PDF
41. Succinyl Curcumin Conjugated Chitosan Polymer-Prodrug Nanomicelles: A Potential Treatment for Type-II Diabetes in Diabetic Balb/C Mice.
- Author
-
Sk Mosiur R, Dutta G, Biswas R, Sugumaran A, M Salem M, Gamal M, AbdElrahman M, and M Salem-Bekhit M
- Subjects
- Animals, Mice, Nanoparticles chemistry, Male, Blood Glucose drug effects, Blood Glucose metabolism, Hypoglycemic Agents pharmacology, Hypoglycemic Agents administration & dosage, Hypoglycemic Agents chemistry, Curcumin pharmacology, Curcumin therapeutic use, Chitosan chemistry, Diabetes Mellitus, Type 2 drug therapy, Micelles, Mice, Inbred BALB C, Diabetes Mellitus, Experimental drug therapy, Prodrugs chemistry, Prodrugs pharmacology
- Abstract
Diabetes mellitus is a chronic metabolic disorder marked by elevated blood sugar levels, leading to organ dysfunction. Curcumin, derived from turmeric, exhibits promise in managing type II diabetes. Nanomicelles were created by conjugating curcumin with chitosan through succinic anhydride. Succinyl-curcumin, the resultant compound, was esterified with chitosan to form a polymer prodrug conjugate. Nanomicelles, formed via dialysis, were spherical with a hydrodynamic size of 49.37 nm. In vitro release studies revealed 97% curcumin release at pH 5 in 7 days. A 21-day experiment on diabetic mice compared nanomicelles, standard drug, and free curcumin's impact on fasting blood glucose. The study showcased gradual, controlled curcumin release from nanomicelles, suggesting their potential in type II diabetes treatment.
- Published
- 2024
- Full Text
- View/download PDF
42. Curcumin attenuates brain aging by reducing apoptosis and oxidative stress.
- Author
-
Cheriki M, Habibian M, and Moosavi SJ
- Subjects
- Animals, Female, Rats, Antioxidants pharmacology, Neuroprotective Agents pharmacology, Neuroprotective Agents therapeutic use, Superoxide Dismutase metabolism, Lipid Peroxidation drug effects, Curcumin pharmacology, Curcumin therapeutic use, Oxidative Stress drug effects, Apoptosis drug effects, Rats, Wistar, Aging drug effects, Aging metabolism, Brain drug effects, Brain metabolism, Brain-Derived Neurotrophic Factor metabolism, Vascular Endothelial Growth Factor A metabolism, Vascular Endothelial Growth Factor A drug effects
- Abstract
Brain aging is a physiological event, and oxidative stress and apoptosis are involved in the natural aging process of the brain. Curcumin is a natural antioxidant with potent anti-aging and neuroprotective properties. Therefore, we investigated the protective effects of curcumin on brain apoptosis and oxidative stress, brain-derived neurotrophic factor (BDNF), and vascular endothelial growth factor (VEGF) in aged rats. Old female Wistar rats were randomly divided into three groups (n = 7); as follows: (1) control; (2); saline and (3) curcumin (received 30 mg/kg of curcumin, 5 days/week for 8 weeks, intraperitoneally). Our results indicated that treatment with curcumin in aged rats attenuates brain lipid peroxidation, which was accompanied by a significant increase in the BDNF, VEGF, superoxide dismutase (SOD) activity, and anti-apoptotic protein BCl-2. No significant change in brain anti-apoptotic Bax protein levels was observed after curcumin treatment. The study indicates that curcumin could alleviate brain aging which may be due to attenuating oxidative stress, inhibiting apoptosis, and up-regulating SOD activity, which in turn enhances VEGF and BDNF. Therefore, curcumin has potential therapeutic value in the treatment of neurological apoptosis, neurogenesis, and angiogenesis changes caused by brain aging., (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
43. NF-κB pathway as a molecular target for curcumin in diabetes mellitus treatment: Focusing on oxidative stress and inflammation.
- Author
-
Zamanian MY, Alsaab HO, Golmohammadi M, Yumashev A, Jabba AM, Abid MK, Joshi A, Alawadi AH, Jafer NS, Kianifar F, and Obakiro SB
- Subjects
- Inflammation drug therapy, Interleukin-6 metabolism, Tumor Necrosis Factor-alpha metabolism, Insulin-Secreting Cells drug effects, Insulin-Secreting Cells metabolism, Insulin blood, Streptozocin, Blood Glucose drug effects, Signal Transduction drug effects, Animals, Rats, Calcium-Calmodulin-Dependent Protein Kinase Type 2 metabolism, Chemokine CCL2 metabolism, Diabetic Cardiomyopathies prevention & control, Gastroparesis prevention & control, Diabetic Neuropathies prevention & control, Mice, NF-kappa B metabolism, Curcumin chemistry, Curcumin pharmacology, Curcumin therapeutic use, Oxidative Stress drug effects, Diabetes Mellitus drug therapy, Diabetes Mellitus metabolism, Diabetes Mellitus, Experimental drug therapy, Diabetes Mellitus, Experimental metabolism
- Abstract
Diabetes mellitus (DM) is a collection of metabolic disorder that is characterized by chronic hyperglycemia. Recent studies have demonstrated the crucial involvement of oxidative stress (OS) and inflammatory reactions in the development of DM. Curcumin (CUR), a natural compound derived from turmeric, exerts beneficial effects on diabetes mellitus through its interaction with the nuclear factor kappa B (NF-κB) pathway. Research indicates that CUR targets inflammatory mediators in diabetes, including tumor necrosis factor α (TNF-α) and interleukin-6 (IL-6), by modulating the NF-κB signaling pathway. By reducing the expression of these inflammatory factors, CUR demonstrates protective effects in DM by improving pancreatic β-cells function, normalizing inflammatory cytokines, reducing OS and enhancing insulin sensitivity. The findings reveal that CUR administration effectively lowered blood glucose elevation, reinstated diminished serum insulin levels, and enhanced body weight in Streptozotocin -induced diabetic rats. CUR exerts its beneficial effects in management of diabetic complications through regulation of signaling pathways, such as calcium-calmodulin (CaM)-dependent protein kinase II (CaMKII), peroxisome proliferator-activated receptor gamma (PPAR-γ), NF-κB, and transforming growth factor β1 (TGFB1). Moreover, CUR reversed the heightened expression of inflammatory cytokines (TNF-α, Interleukin-1 beta (IL-1β), IL-6) and chemokines like MCP-1 in diabetic specimens, vindicating its anti-inflammatory potency in counteracting hyperglycemia-induced alterations. CUR diminishes OS, avert structural kidney damage linked to diabetic nephropathy, and suppress NF-κB activity. Furthermore, CUR exhibited a protective effect against diabetic cardiomyopathy, lung injury, and diabetic gastroparesis. Conclusively, the study posits that CUR could potentially offer therapeutic benefits in relieving diabetic complications through its influence on the NF-κB pathway., (© 2024 John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
44. Curcumin and Ferroptosis: a Promising Target for Disease Prevention and Treatment.
- Author
-
Foroutan Z, Butler AE, Zengin G, and Sahebkar A
- Subjects
- Humans, Animals, Neoplasms drug therapy, Neoplasms metabolism, Neoplasms pathology, Signal Transduction drug effects, Lipid Peroxidation drug effects, Antioxidants pharmacology, Antioxidants therapeutic use, Ferroptosis drug effects, Curcumin pharmacology, Curcumin therapeutic use
- Abstract
Ferroptosis is a recently identified form of cell death characterized by iron accumulation and lipid peroxidation. Unlike apoptosis, necrosis, and autophagy, ferroptosis operates through a distinct molecular pathway. Curcumin, derived from turmeric rhizomes, is a natural compound with diverse therapeutic benefits, including neuroprotective, anti-metabolic syndrome, anti-inflammatory, and anti-cancer properties. Growing evidence suggests that curcumin possesses both pro-oxidant and antioxidant properties, which can vary depending on the cell type. In this review, we explore the relationship between the effects of curcumin and the molecular mechanisms underlying the ferroptosis signaling pathway, drawing from current in vivo and in vitro research. Curcumin has been found to induce ferroptosis in cancer cells while acting as an inhibitor of ferroptosis in tissue injuries. Notably, curcumin treatment leads to alterations in key ferroptosis markers, underscoring its significant impact on this process. Nonetheless, further research focused on elucidating this important attribute of turmeric is crucial for advancing disease treatment., (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
45. Neuroprotective and anti-inflammatory effects of curcumin in Alzheimer's disease: Targeting neuroinflammation strategies.
- Author
-
Azzini E, Peña-Corona SI, Hernández-Parra H, Chandran D, Saleena LAK, Sawikr Y, Peluso I, Dhumal S, Kumar M, Leyva-Gómez G, Martorell M, Sharifi-Rad J, and Calina D
- Subjects
- Humans, Animals, Neuroinflammatory Diseases drug therapy, Antioxidants pharmacology, Curcuma chemistry, Biological Availability, Curcumin pharmacology, Curcumin therapeutic use, Alzheimer Disease drug therapy, Neuroprotective Agents pharmacology, Anti-Inflammatory Agents pharmacology
- Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by the accumulation of amyloid-beta plaques and neurofibrillary tangles, leading to neuronal loss. Curcumin, a polyphenolic compound derived from Curcuma longa, has shown potential neuroprotective effects due to its anti-inflammatory and antioxidant properties. This review aims to synthesize current preclinical data on the anti-neuroinflammatory mechanisms of curcumin in the context of AD, addressing its pharmacokinetics, bioavailability, and potential as a therapeutic adjunct. An exhaustive literature search was conducted, focusing on recent studies within the last 10 years related to curcumin's impact on neuroinflammation and its neuroprotective role in AD. The review methodology included sourcing articles from specialized databases using specific medical subject headings terms to ensure precision and relevance. Curcumin demonstrates significant neuroprotective properties by modulating neuroinflammatory pathways, scavenging reactive oxygen species, and inhibiting the production of pro-inflammatory cytokines. Despite its potential, challenges remain regarding its limited bioavailability and the scarcity of comprehensive human clinical trials. Curcumin emerges as a promising therapeutic adjunct in AD due to its multimodal neuroprotective benefits. However, further research is required to overcome challenges related to bioavailability and to establish effective dosing regimens in human subjects. Developing novel delivery systems and formulations may enhance curcumin's therapeutic potential in AD treatment., (© 2024 John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
46. Curcumin supplementation as a complementary and alternative medicine for COVID-19 patients.
- Author
-
Aghakhani N and Soraya H
- Subjects
- Humans, COVID-19, SARS-CoV-2, Curcumin therapeutic use, COVID-19 Drug Treatment, Complementary Therapies methods, Dietary Supplements
- Published
- 2024
- Full Text
- View/download PDF
47. Curcumin relieves oxaliplatin-induced neuropathic pain via reducing inflammation and activating antioxidant response.
- Author
-
Zhang MW, Sun X, Xu YW, Meng W, Tang Q, Gao H, Liu L, and Chen SH
- Subjects
- Animals, Mice, Male, Mice, Inbred C57BL, Oxidative Stress drug effects, Inflammasomes metabolism, Inflammasomes drug effects, Disease Models, Animal, NLR Family, Pyrin Domain-Containing 3 Protein metabolism, Spinal Cord metabolism, Spinal Cord drug effects, Hyperalgesia drug therapy, Hyperalgesia chemically induced, Hyperalgesia metabolism, NF-E2-Related Factor 2 metabolism, Oxaliplatin adverse effects, Neuralgia chemically induced, Neuralgia drug therapy, Neuralgia metabolism, Curcumin pharmacology, Curcumin therapeutic use, Antioxidants pharmacology, Glycogen Synthase Kinase 3 beta metabolism, Inflammation metabolism, Inflammation drug therapy, Inflammation chemically induced
- Abstract
Oxaliplatin (OXA) has shown high effectiveness in the treatment of cancers, but its anticancer clinical effects often induce neurotoxicity leading to neuropathic pain. Oxidative damage and NLRP3 inflammasome play important roles in neuropathic pain development. Here, neuropathic pain mouse model was constructed by continuous intraperitoneal injection of OXA. OXA administration induced mechanical pain, spontaneous pain, thermal hyperalgesia and motor disability in mice. The spinal cord tissues of OXA mice exhibited the suppressed antioxidative response, the activated NLRP3 inflammasome mediated inflammatory responses, and the increased GSK-3β activity. Next, we injected curcumin (CUR) intraperitoneally in OXA mice for seven consecutive days. CUR-treated mice showed increased mechanical pain thresholds, reduced number of spontaneous flinches, increased paw withdrawal latency, and restored latency to fall. While in the spinal cord, CUR treatment inhibited the NLRP3 inflammasome mediated inflammatory response, increased Nrf2/GPX4-mediated antioxidant responses, and decreased mitochondrial oxidative generation. Additionally, CUR combined with GSK-3β through four covalent bonds and reduced GSK-3β activity. In conclusion, our findings suggest that CUR treatment inhibits GSK-3β activation, increases Nrf2 mediated antioxidant responses, inhibits oxidative damage and inflammatory reaction, and alleviates OXA-induced neuropathic pain., (© 2024 International Federation of Cell Biology.)
- Published
- 2024
- Full Text
- View/download PDF
48. Protective mechanism of curcumin on lipopolysaccharide induced acute lung injury through Nrf2/ARE signaling pathway.
- Author
-
Wang C, Zhu W, and Xing J
- Subjects
- Animals, Antioxidant Response Elements drug effects, Disease Models, Animal, Lung drug effects, Lung metabolism, Lung pathology, Mice, Oxidative Stress drug effects, NF-E2-Related Factor 2 metabolism, Signal Transduction drug effects, Curcumin pharmacology, Curcumin therapeutic use, Acute Lung Injury chemically induced, Acute Lung Injury metabolism, Acute Lung Injury drug therapy, Lipopolysaccharides
- Published
- 2024
- Full Text
- View/download PDF
49. Two by Two Factorial Design using Metformin and Curcumin for Second Primary Head and Neck Cancer Prevention Trial.
- Author
-
Kekatpure V, Subramaniam N, Sunny S, Nambiar S, Sarah T, Vasudevan V, Rao A, Murali A, Kolur T, Krishnamurthy A, Kantharia R, Nair SV, Thankappan K, M N B, Kumar R, Balasubramanian S, Toprani R, Agrawala S, Battoo AJ, Bakshi J, Babu S, Shah S, Trivedi N, Selvam S, Kannan R, Kumar A, Suresh A, Pillai V, Chaturvedi P, Iyer S, and Kuriakose MA
- Subjects
- Adult, Aged, Female, Humans, Male, Middle Aged, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Double-Blind Method, Follow-Up Studies, Prognosis, Randomized Controlled Trials as Topic, Research Design, Squamous Cell Carcinoma of Head and Neck prevention & control, Squamous Cell Carcinoma of Head and Neck drug therapy, Clinical Trials, Phase II as Topic, Multicenter Studies as Topic, Clinical Trials, Phase III as Topic, Curcumin therapeutic use, Head and Neck Neoplasms prevention & control, Head and Neck Neoplasms drug therapy, Metformin therapeutic use, Neoplasms, Second Primary prevention & control
- Abstract
Objective: The 2x2 factorial design is an effective method that allows for multiple comparisons, especially in the context of interactions between different interventions, without substantially increasing the required sample size. In view of the considerable preclinical evidence for Curcumin and Metformin in preventing the development and progression of head and neck squamous cell carcinoma (HNSCC), this study describes the protocol of the clinical trial towards applying the drug combination in prevention of second primary tumors., Methods: We have applied the trial design to a large phase IIB/III double-blind, multi-centric, placebo-controlled, randomized clinical trial to determine the safety and efficacy of Metformin and Curcumin in the prevention of second primary tumours (SPT) of the aerodigestive tract following treatment of HNSCC (n=1,500) [Clinical Registry of India, CTRI/2018/03/012274]. Patients recruited in this trial will receive Metformin (with placebo), Curcumin (with placebo), Metformin, and Curcumin or placebo alone for a period of 36 months. The primary endpoint of this trial is the development of SPT, while the secondary endpoints are toxicities associated with the agents, incidence of recurrence, and identifying potential biomarkers. In this article, we discuss the 2x2 factorial design and how it applies to the head and neck cancer chemoprevention trial., Conclusion: 2x2 factorial design is an effective trial design for chemoprevention clinical trials where the effectiveness of multiple interventions needs to be tested parallelly.
- Published
- 2024
- Full Text
- View/download PDF
50. Phytomedicine for neurodegenerative diseases: The road ahead.
- Author
-
Madhubala D, Patra A, Khan MR, and Mukherjee AK
- Subjects
- Humans, Curcumin therapeutic use, Curcumin pharmacology, Quercetin pharmacology, Quercetin therapeutic use, Animals, Cannabinoids therapeutic use, Cannabinoids pharmacology, Apigenin pharmacology, Apigenin therapeutic use, Blood-Brain Barrier drug effects, Phytochemicals pharmacology, Phytochemicals therapeutic use, Plant Extracts therapeutic use, Plant Extracts pharmacology, Neurodegenerative Diseases drug therapy, Catechin analogs & derivatives, Catechin therapeutic use, Catechin pharmacology, Phytotherapy
- Abstract
Neurodegenerative disorders (NDs) are among the most common causes of death across the globe. NDs are characterized by progressive damage to CNS neurons, leading to defects in specific brain functions such as memory, cognition, and movement. The most common NDs are Parkinson's, Alzheimer's, Huntington's, and amyotrophic lateral sclerosis (ALS). Despite extensive research, no therapeutics or medications against NDs have been proven to be effective. The current treatment of NDs involving symptom-based targeting of the disease pathogenesis has certain limitations, such as drug resistance, adverse side effects, poor blood-brain barrier permeability, and poor bioavailability of drugs. Some studies have shown that plant-derived natural compounds hold tremendous promise for treating and preventing NDs. Therefore, the primary objective of this review article is to critically analyze the properties and potency of some of the most studied phytomedicines, such as quercetin, curcumin, epigallocatechin gallate (EGCG), apigenin, and cannabinoids, and highlight their advantages and limitations for developing next-generation alternative treatments against NDs. Further extensive research on pre-clinical and clinical studies for developing plant-based drugs against NDs from bench to bedside is warranted., (© 2024 John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.